MAM
DTIL icon

Meeder Asset Management’s Precision BioSciences DTIL Stock Holding History

Meeder Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14
Closed -$3K – 2146
2020
Q1 		$3K Sell
14
-11
-44% -$2.88K ﹤0.01% 1942
2019
Q4 		$10K Buy
+25
New +$7.86K ﹤0.01% 1552

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Meeder Asset Management's DTIL Position: Q2 2020 in Review

Meeder Asset Management sold out of Precision BioSciences (DTIL) in Q2 2020, closing a stake of 14 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in DTIL in Q4 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 115 funds tracked by Wall St. Rank hold DTIL as of Q2 2020.

  • Meeder Asset Management reported no remaining Precision BioSciences position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 14 Precision BioSciences shares in Q2 2020, an estimated $3K.
  • Meeder Asset Management first reported a position in Precision BioSciences in Q4 2019 and held it in 2 quarters.
  • Meeder Asset Management's Precision BioSciences position peaked at $10K in Q4 2019.
  • 115 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.